If you have traveled to any area in the US that is considered a “hot spot” with increasing amount of cases of COVID please alert our office before coming in for any appointment. All VCS sites will be conducting temperature checks for all patients and visitors at entrances. For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. FOR THE LATEST UP TO DATE INFORMATION, ALERTS AND CANCELLATIONS PLEASE CLICK HERE

Robert L. Marsh, MD

VCS Physicians

Robert L. Marsh, MD Headshot

Modern progress and therapeutics continuously inspire me; how much more can be offered to our patients. I am honored daily to earn my patients trust, while offering my very best - I will always treat them with the importance and respect they deserve.

Work and Credentials:

Primary Location

Gainesville Office

Position

Medical Oncologist

Board Certification

Medical Oncology and Hematology

Fellowship

University of Florida College of Medicine, Medical Oncology and Hematology

Internship

University of Florida College of Medicine

Residency

University of Florida College of Medicine

Medical School

University of Illinois Medical Center

College

University of Illinois

Dr. Marsh received his doctorate of medicine from the University of Illinois Medical Center and completed his internship, residency and fellowship at the University of Florida College of Medicine, Gainesville, where he was honored with the National Service Award, National Institutes of Health.

Dr. Marsh is a published author and has been a principal research investigator for several cancer related drug studies. During his spare time, he is a Volunteer Trainer for the Prince William County 4-H Bull’s-Eye Shooting Sports Club.


Practice Blog

September 7, 2017

Robert L. Marsh, MD

Read More

Clinical Trials (1)

Clinical Trial 19200

MIRASOL: A Randomized, Open-label, Phase 3 Study of Mirvetuximab Soravtansine vs. Investigator's Choice of Chemotherapy in Platinum-Resistant, Advanced High-grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers with High Folate Receptor-Alpha Expression (IMGN853-0416)

Primary Location

Gainesville Office Office

Gainesville Office

Learn More

Other Locations

Awards

January 1, 2019

Northern Virginia Magazine Top Doctor 2019


January 1, 2018
Northern Virginia Magazine Top Doctor 2018

Northern Virginia Magazine Top Doctors 2018


February 1, 2015
Northern Virginia Magazine

Top Doctor 2015


January 31, 2014
Northern Virginia Magazine

Top Doctor 2014


January 31, 2013
Northern Virginia Magazine

Top Doctor 2013


February 29, 2012
Washingtonian Magazine

Top Doctor 2012